BraCoLi

BraCoLi provides a curated electronic repository of chemical compounds to support computer-aided drug design and medicinal chemistry research.

Key Features:

• Compound collection: The first release comprises 1,176 compounds selected to enhance chemical diversity and drug-likeness profiles.
• Drug-likeness criteria: Compounds were characterized for adherence to Lipinski’s Rule of Five and Veber’s rules, indicating many possess properties conducive to oral bioavailability.
• Chemical space analysis: Principal component analysis (PCA) was used to reveal structural and physicochemical patterns.
• Database comparison: Structural and physicochemical patterns were compared with FDA-approved drugs and NuBBE_DB.
• Similarity metrics: Tanimoto coefficient values show low similarity between BraCoLi compounds and those from compared databases, indicating different kernel distributions.
• Scaffold diversity: Scaffold analysis identifies numerous privileged chemical scaffolds within the collection.
• Unique properties: The library provides compounds with distinctive structural and physicochemical properties while maintaining drug-like characteristics.

Scientific Applications:

• Computer-aided drug design: Supports in silico drug design efforts by supplying curated, drug-like compounds.
• Medicinal chemistry: Provides privileged scaffolds and diverse chemical matter for medicinal chemistry investigations and scaffold-based exploration.
• Pharmacology research: Offers structurally diverse compounds for pharmacological hypothesis generation and structure–activity relationship studies.
• Comparative chemoinformatics: Enables comparison of chemical space and similarity metrics against FDA-approved drugs and NuBBE_DB to identify unique kernels of chemical matter.
• Novel therapeutic discovery: Supplies a distinctive chemical space that complements existing compound libraries for exploration of new therapeutic leads.

Methodology:

Analyses explicitly reported include principal component analysis (PCA), calculation of Tanimoto coefficients, scaffold analysis, and evaluation against Lipinski’s Rule of Five and Veber’s rules.